Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Disappearance rate of symptoms
研究概览
简要总结
A retrospective analysis was conducted on patients infected with the Omicron variant of COVID-19 diagnosed from August 2022 to now. Patients were divided into observation groups and control groups according to whether or not oral Lianhua Qingwen granules were used. Through data analysis and follow-up, the effectiveness of Lianhua Qingwen in treating patients infected with the Omicron variant of COVID-19 was discussed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •For patients infected with the Omicron variant, the diagnostic criteria are confirmed cases of COVID-19 and clinical classification according to the diagnostic criteria of Prevention and Control Protocol for COVID-19 (Trial Eighth Edition) issued by the National Health and Construction Commission.
- •The clinical symptoms were classified as mild or ordinary.
- •They have been vaccinated against the COVID-19.
排除标准
- •Patients receiving antiviral or antibiotic drugs
- •Severe and critical patients with COVID-
- •Patients with chronic respiratory diseases, bacterial infections of the respiratory system, and other respiratory diseases affecting the study.
- •Patients with serious primary diseases of the heart, brain, lung, liver, kidney, and hematopoietic systems, as well as mental diseases.
- •Allergic reaction to Lianhua Qingwen granules.
- •Excluded patients treated with the same drug as Lianhua Qingwen.
研究组 & 干预措施
Control group
Patients without Lianhua Qingwen treatment.
干预措施: The group of patients who did not receive Lianhua Qingwen orally (Other)
Observation Group
Patients with Lianhua Qingwen treatment.
干预措施: The group of patients who received Lianhua Qingwen orally (Drug)
结局指标
主要结局
Disappearance rate of symptoms
时间窗: two weeks
Disappearance rate of symptoms (fever, fatigue, cough)
次要结局
未报告次要终点
研究者
Qian Qi
Dr.
Qianfoshan Hospital